Sunshine Biopharma (SBFM) FCF Margin (2015 - 2026)
Sunshine Biopharma's (SBFM) quarterly FCF Margin came in at 25.68% in Q1 2026, down 655.0% YoY from 4.63% in Q1 2025, and down 36.39% on a QoQ basis from 18.83% in Q4 2025.
Sunshine Biopharma (SBFM) FCF Margin (2015 - 2026) Analysis & Trends
Sunshine Biopharma (SBFM) has 10 years of FCF Margin data on file, last reported at 25.68% in Q1 2026.
- Quarterly FCF Margin fell 655.0% year-over-year to 25.68% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 16.57% (up 1831.0% YoY) and the FY2025 annual result came in at 15.16%, up 2550.0% from the prior year.
- FCF Margin declined to 25.68% in Q1 2026, from 18.83% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 7.81% in Q3 2025 to a low of 1063.4% in Q1 2022.
- A 5-year average of 161.49% and a median of 36.56% in 2024 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2022 — FCF Margin plunged 32109 bps — and 2023, when it jumped 102560 bps.
- Tracing SBFM's FCF Margin over 5 years: stood at 61.95% in 2022, then jumped by 52 bps to 30.04% in 2023, then dropped by 22 bps to 36.56% in 2024, then surged by 48 bps to 18.83% in 2025, then sank by 36 bps to 25.68% in 2026.
- The last three FCF Margin figures came in at 25.68% (Q1 2026), 18.83% (Q4 2025), and 7.81% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 7.41% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 21.80% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 14.87% |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 26.25% |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 8.76% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 13.41% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 17.84% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Sunshine Biopharma | 1.54 Mn | -12.21 Mn | 2.43 Mn | -9.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9.99% |
| Mar 31, 2026 | -25.68% |
| Dec 31, 2025 | -18.83% |
| Sep 30, 2025 | -7.81% |
| Jun 30, 2025 | -15.43% |
| Mar 31, 2025 | -19.13% |
| Dec 31, 2024 | -36.56% |
| Sep 30, 2024 | -22.21% |
| Jun 30, 2024 | -59.68% |
| Mar 31, 2024 | -43.07% |
| Dec 31, 2023 | -30.04% |
| Sep 30, 2023 | -7.84% |
| Jun 30, 2023 | -67.94% |
| Mar 31, 2023 | -37.80% |
| Dec 31, 2022 | -61.95% |
| Sep 30, 2022 | -846.14% |
| Jun 30, 2022 | -381.75% |
| Mar 31, 2022 | -1,063.40% |
| Dec 31, 2021 | -366.68% |
| Sep 30, 2021 | -1,192.65% |